- Today
- Holidays
- Birthdays
- Reminders
- Cities
- Atlanta
- Austin
- Baltimore
- Berwyn
- Beverly Hills
- Birmingham
- Boston
- Brooklyn
- Buffalo
- Charlotte
- Chicago
- Cincinnati
- Cleveland
- Columbus
- Dallas
- Denver
- Detroit
- Fort Worth
- Houston
- Indianapolis
- Knoxville
- Las Vegas
- Los Angeles
- Louisville
- Madison
- Memphis
- Miami
- Milwaukee
- Minneapolis
- Nashville
- New Orleans
- New York
- Omaha
- Orlando
- Philadelphia
- Phoenix
- Pittsburgh
- Portland
- Raleigh
- Richmond
- Rutherford
- Sacramento
- Salt Lake City
- San Antonio
- San Diego
- San Francisco
- San Jose
- Seattle
- Tampa
- Tucson
- Washington
North Chicago Today
By the People, for the People
Captrust Financial Advisors Boosts Position in AbbVie Inc.
Institutional investor increases stake in pharmaceutical company AbbVie
Mar. 18, 2026 at 8:36am
Got story updates? Submit your updates here. ›
Captrust Financial Advisors, an institutional investor, has increased its holdings in AbbVie Inc. (NYSE:ABBV) by 2.7% in the third quarter, according to a recent disclosure with the Securities & Exchange Commission. Captrust now owns 1,474,836 shares of the company's stock, worth approximately $341 million.
Why it matters
AbbVie is a major pharmaceutical company that develops and commercializes therapies for complex and chronic medical conditions. Institutional investors like Captrust closely monitor and adjust their positions in large pharmaceutical stocks like AbbVie, which can provide insights into market sentiment and expectations around the company's performance.
The details
According to the disclosure, Captrust Financial Advisors purchased an additional 38,309 shares of AbbVie in the third quarter, increasing its total position to 1,474,836 shares. This represents about 0.08% of AbbVie's outstanding shares. The purchase was part of Captrust's broader investment strategy and portfolio management for its clients.
- Captrust Financial Advisors increased its AbbVie holdings in the third quarter of 2026.
The players
Captrust Financial Advisors
An institutional investment firm that manages assets for clients such as pension funds, endowments, foundations, and high-net-worth individuals.
AbbVie Inc.
A global biopharmaceutical company that develops and commercializes therapies for complex and chronic medical conditions, including immunology, oncology, neuroscience, virology, and women's health.
The takeaway
The increase in Captrust's AbbVie holdings suggests the institutional investor sees continued growth potential in the pharmaceutical company, despite some market volatility. This is a positive signal for AbbVie as it navigates the competitive landscape of the healthcare industry.
